Article
Transcriptional Profiling of Rapamycin-Treated Fibroblasts From Hypertrophic and Keloid Scars
16 May 2014
Abstract excerpt
Excess scar formation after cutaneous injury can result in hypertrophic scar (HTS) or keloid formation. Modern strategies to treat pathologic scarring represent nontargeted approaches that produce suboptimal results. Mammalian target of rapamycin (mTOR), a central mediator of inflammation, has been proposed as a novel target to block fibroproliferation. To examine its mechanism of action, we performed genomewide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
